KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production (Q73635302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Y Morimoto

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Nishikawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Ohashi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

795-803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

The expression of TNF alpha by human muscle. Relationship to insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Processing of tumour necrosis factor-α precursor by metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Augmented production of tumor necrosis factor-alpha in obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Regulation of glucose transport by pioglitazone in cultured muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900561-4

10.1016/S0024-3205(97)00561-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9275009%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference